首页> 外文期刊>Bone marrow transplantation >Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease.
【24h】

Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease.

机译:合并使用G-CSF + GM-CSF与单独使用G-CSF来动员患有恶性疾病的儿童外周血干细胞。

获取原文
获取原文并翻译 | 示例
       

摘要

There is limited experience in the mobilization of peripheral blood progenitor cells (PBPC) in children and the optimal method for PBPC mobilization is unknown. The present study was conducted to ascertain whether mobilization with G-CSF + GM-CSF (group I) provides some advantage over G-CSF alone (group II) in terms of collected CD34+ cells and hematopoietic recovery following myeloablative conditioning in children with malignancies. An economic analysis was also performed. Each group comprised 21 consecutive patients. The mean number of aphereses was 1.5+/-0.5 in group I and 1.2+/-0.46 in group II (NS). The mean number of CD34+ cells was 3.8 x 106+/-4.03/kg in group I and 4.2+/-5.4 in group II (NS). The mean number of total blood volumes (TBV) processed was 4.4+/-1.5 in group I and 4.3+/-1.5 in group II (NS). The mean duration of the procedure was 276+/-74.1 min in group I and 286.7+/-75.9 min in group II (NS), and the inlet flow was 45.1+/-12 ml/min in group I and 39.5+/-15.1 ml/min in group II (NS). No significant differences in the neutrophil and platelet engraftment probability were observed between the two groups. The mean overall cost of group II was not statistically significant from that of group I (US
机译:儿童动员外周血祖细胞(PBPC)的经验有限,动员PBPC的最佳方法尚不清楚。进行本研究是为了确定在恶性肿瘤患儿骨髓清扫条件下收集的CD34 +细胞和造血恢复方面,用G-CSF + GM-CSF(I组)的动员是否比单独使用G-CSF(II组)更具优势。还进行了经济分析。每组包括21名连续患者。 I组中平均无球菌数量为1.5 +/- 0.5,II组中为(NS)平均球菌数量为1.2 +/- 0.46。 I组的平均CD34 +细胞数量为3.8 x 106 +/- 4.03 / kg,II组的(NS)平均为4.2 +/- 5.4。第一组的平均总血容量(TBV)为4.4 +/- 1.5,第二组(NS)为4.3 +/- 1.5。 I组的平均手术时间为276 +/- 74.1分钟,II组(NS)的平均手术时间为286.7 +/- 75.9分钟,I组的进气流量为45.1 +/- 12 ml / min,39.5 + / II组(NS)-15.1 ml / min。两组之间在中性粒细胞和血小板植入几率上没有显着差异。第II组的平均总体费用与第I组相比没有统计学意义(美国

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号